Further transcriptomic analysis revealed that the anti-tumor effects of PKU12-based siRNA delivery may be associated with modulating of HIF-1 signaling, TNF signaling, NF-kappa B signaling, ferroptosis, IL-17 signaling pathways. This evidence concerns the gene IL17A and neoplasm.